Difebarbamate(INN) is atranquilizerof thebarbiturateandcarbamatefamilies which is used inEuropeas a component of acombination drugformulationreferred to astetrabamate(Atrium,Sevrium).[1][2][3]

Difebarbamate
Clinical data
Routes of
administration
Oral
ATC code
  • None
Identifiers
  • (5-ethyl-2,4,6-trioxo-5-phenyldihydropyrimidine-1,3(2H,4H)-diyl)bis-3-butoxypropane-1,2-diyl dicarbamate
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.036.147Edit this at Wikidata
Chemical and physical data
FormulaC28H42N4O9
Molar mass578.663g·mol−1
3D model (JSmol)
  • O=C1N(C(=O)N(C(=O)C1(c2ccccc2)CC)CC(OC(=O)N)COCCCC)CC(OC(=O)N)COCCCC
  • InChI=1S/C28H42N4O9/c1-4-7-14-38-18-21(40-25(29)35)16-31-23(33)28(6-3,20-12-10-9-11-13-20)24(34)32(27(31)37)17-22(41-26(30)36)19-39-15-8-5-2/h9-13,21-22H,4-8,14-19H2,1-3H3,(H2,29,35)(H2,30,36)
  • Key:GJJRIOLBUILIGK-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^Index nominum 2000: international drug directory.Taylor & Francis US. 2000. p. 333.ISBN978-3-88763-075-1.Retrieved26 November2011.
  2. ^World Health Organization (2004)."The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance"(PDF).
  3. ^Vachta J, Valter K, Siegfried B (1990). "Metabolism of difebarbamate in man".European Journal of Drug Metabolism and Pharmacokinetics.15(3): 191–8.doi:10.1007/BF03190203.PMID2253648.S2CID2916646.